The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

nu-lens.com

Founded Year

2002

Stage

Other Investors | Alive

About NuLens

NuLens researches, develops and markets technologies for the ophthalmic markets. The company is currently developing a new Accommodative Intraocular Lens (IOL) technology with the potential to provide over 10 diopters of accommodative power. This exciting innovation, based on the patents of Dr. Joshua Ben Nun, will prove to be a intraocular lens to provide real, comfortable, and lasting accommodation for near, intermediate and far distances - the way nature intended. Not only does it restore eyesight, it aims to provide better eyesight than ever before. NuLens (is) one of a truly accommodating IOLs with accommodative amplitudes far in excess of any other current single or dual optic designs ( American Academy of Ophthalmology )

NuLens Headquarter Location

Maskit 15

46121,

Israel

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

NuLens Patents

NuLens has filed 12 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/15/2014

11/14/2017

Eye surgery, Ophthalmology, Vision, Corrective lenses, Sulci (neuroanatomy)

Grant

Application Date

9/15/2014

Grant Date

11/14/2017

Title

Related Topics

Eye surgery, Ophthalmology, Vision, Corrective lenses, Sulci (neuroanatomy)

Status

Grant

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.